Previous Article | Next Article ![]()
Molecular and Cellular Biology, August 2001, p. 4960-4967, Vol. 21, No. 15
Division of Basic Biomedical Sciences,
University of South Dakota School of Medicine, Vermillion, South
Dakota 57069
Received 14 August 2000/Returned for modification 27 September
2000/Accepted 3 May 2001
p27 is a key regulator of cell proliferation through inhibition of
G1 cyclin-dependent kinase (CDK) activity. Translation of
the p27 mRNA is an important control mechanism for determining cellular
levels of the inhibitor. Nearly all eukaryotic mRNAs are translated
through a mechanism involving recognition of the 5' cap by eukaryotic
initiation factor 4E (eIF4E). In quiescent cells eIF4E activity is
repressed, leading to a global decline in translation rates. In
contrast, p27 translation is highest during quiescence, suggesting that
it escapes the general repression of translational initiation. We show
that the 5' untranslated region (5'-UTR) of the p27 mRNA mediates
cap-independent translation. This activity is unaffected by conditions
in which eIF4E is inhibited. In D6P2T cells, elevated cyclic AMP levels
cause a rapid withdrawal from the cell cycle that is correlated with a
striking increase in p27. Under these same conditions, cap-independent
translation from the p27 5'-UTR is enhanced. These results indicate
that regulation of internal initiation of translation is an important
determinant of p27 protein levels.
In normal cells, the
cyclin-dependent kinase (CDK) inhibitor p27 mediates cell cycle arrest
during contact inhibition, during cellular differentiation, and in
response to numerous other cellular modulators (3). p27
arrests cells in G1 primarily by inhibition of CDK2, which
is required for the transition into S phase. In cancer cells, p27 is
generally downregulated and there is a strong inverse correlation
between tumor progression and the levels of p27 (3, 20).
Loss of p27 expression in tumor cells is not due to mutations in the
gene that encodes the inhibitor (4, 7, 14, 32) and so must
reflect changes in the regulatory pathways that control p27 expression.
In addition, changes in p27 protein levels in normal cells do not in
general correlate with changes in transcription of the p27 gene.
Rather, p27 is most commonly regulated by changes in the rate of
proteasome-mediated degradation (30) or the rate at which
its mRNA is translated (1, 10, 25).
Nearly all nucleus-encoded eukaryotic proteins are translated through a
mechanism that involves recognition of the mRNA 5' 7-methylguanosine
cap by eukaryotic initiation factor 4E (eIF4E). Through its association
with eIF4G, eIF4E binding to the cap results in recruitment of the 40S
ribosomal subunit. eIF4E cap recognition has been shown to be the
rate-limiting factor in translational initiation (6).
eIF4E activity is modulated by several mechanisms. Its gene is
transcriptionally regulated in response to mitogenic stimulation and
may be a direct target for c-myc (13). The
cap-binding activity of eIF4E is enhanced by phosphorylation. This is
mediated by the protein kinase Mnk (40), which is
downstream of the mitogen-activated protein kinase signaling pathway
and therefore activated in response to numerous mitogenic signals.
Finally, eIF4E is inhibited by interacting with 4E binding protein
(4E-BP, also called PHAS). 4E-BP interacts with the same region of
eIF4E that is bound by eIF4G (9, 22) and thus blocks
assembly of the initiation complex at the 5' end of mRNAs.
Phosphorylation of 4E-BP through the phosphoinositol
3-kinase-dependent pathway blocks its ability to bind eIF4E
(34).
The net result of these eIF4E regulatory mechanisms is that
cap-dependent translation rates are lower in quiescent cells than in
proliferating cells. However, even though global rates of protein synthesis are lower, the p27 mRNA is translated more efficiently in
cells that are quiescent (1, 10, 25). We hypothesized, therefore, that the p27 mRNA escapes the effects of downregulation of
cap-dependent translation by being translated through a cap-independent mechanism. In support of this hypothesis, the results reported here
indicate that the 5' untranslated region (5'-UTR) of the p27 mRNA
functions as an internal ribosome entry site (IRES) and that
translation through this element is enhanced under conditions in which
p27 expression is elevated.
Cell culture.
NIH 3T3 and D6P2T cells were grown in
Dulbecco's modified Eagle medium (DMEM) containing 10% newborn calf
serum, 100 U of penicillin per ml, and 100 µg of streptomycin per ml.
Northern blotting.
Stably transfected NIH 3T3 cells were
harvested in Dulbecco's phosphate-buffered saline and centrifuged to
pellet the cells. A portion of the cells was removed for
chloramphenicol acetyltransferase (CAT) and luciferase assays (see
below). RNA was isolated from the remainder of the cells using TRI
Reagent according to the manufacturer's directions. The RNA was
separated on a 1% agarose gel containing 2.2 M formaldehyde. Following
electrophoresis, the ribosomal bands were visualized by staining in
SybrGold (Molecular Probes) and the RNA was transferred to a nylon
membrane (Schleicher & Schuell). Hybridization was carried out in
PerfectHyb buffer (Sigma) at 68°C. 32P-labeled probes,
consisting of either the CAT coding sequence or the luciferase coding
sequence, were labeled using the RediPrime labeling system (Amersham).
Free 32P was removed by passage through a Sephadex G-50
spin column. Following hybridization, the nylon filter was washed and
the blot was subjected to autoradiography.
Transfections and reporter assays.
Cells were transfected
using GenePorter (Gene Therapy Systems) in medium without added serum
or growth factors. Four hours after transfection, 2 volumes of medium
containing 20% calf serum was added to the cultures. NIH 3T3 cells
were harvested 1 day and D6P2T cells were harvested either 1 or 3 days
after transfection. Cells in 35-mm-diameter culture dishes were
harvested by addition of 200 µl of reporter lysis buffer (Promega)
and scraping from the bottom of the dish.
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.15.4960-4967.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Control of Cyclin-Dependent Kinase Inhibitor p27
Expression by Cap-Independent Translation
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Plasmid constructs. The mouse p27 5'-UTR was amplified from the full-length cDNA (a gift of Tony Hunter) by PCR with primers CTGCGCCTCTCTTCCCCAGA and CTTCCTCCTCGGGCGGGTGT. The PCR product was ligated into the HindIII site of pGL2CAT/Luc (a gift of R. E. Rhoads) which had been end filled and dephosphorylated. Deletion constructs of the p27 5'-UTR were prepared by PCR amplification using primers CTGCGCCTCTCTTCCCCAGA and CGACTGCACACAGACAGTCA for region 1-90 and TGACTGTCTGTGTGCAGTCG and CTTCCTCCTCGGGCGGGTGT for region 71-217. Both PCR products were cloned into pGL2CAT/Luc as described above. To prepare constructs carrying inverted repeat sequences, the luciferase coding region, with or without the p27 5'-UTR at the 5' end, was amplified by PCR and inserted into the end-filled BamHI site of pcDNA3.1hygro (Invitrogen). A double-stranded oligonucleotide containing an inverted repeat sequence (CTAGGGGCGCGTGGTGGCGGCTGCAGCCGCCACCACGCGCCC) was then ligated into the NheI site within the multiple cloning site of the vector.
p27 expression constructs were prepared by amplifying the mouse p27 cDNA using the appropriate primers. For pcDNA-p27-217, the primers used were CTGCGCCTCTCTTCCCCAGA and ATGTCTTCCTTGCTTCATAAAGCAG. For pcDNA-p27-3 the primers used were AAGATGTCAAACGTGAGAGTG and ATGTCTTCCTTGCTTCATAAAGCAG. The PCR products were phosphorylated and made blunt ended using a Perfectly Blunt cloning kit (Novagen). They were then ligated into the NheI site of pcDNA3.1hygro which had been end filled.Western blotting. For Western blotting, cultured cells were harvested directly in sodium dodecyl sulfate (SDS)-sample buffer. Nucleic acids were sheared by sonication. The samples were separated by SDS-polyacrylamide gel electrophoresis and transferred to Immobilon P membranes using a semidry transfer apparatus. p27 was detected using a monoclonal antibody (Transduction Laboratories), a horseradish peroxidase-conjugated secondary antibody, and SuperSignal chemiluminescence reagents (Pierce Chemical Co.). 4E-BP was detected using a polyclonal antibody to PHAS (Zymed). V5 epitope-tagged p27 was detected using a monoclonal antibody to V5 (Invitrogen).
Polysome gradients. Cycloheximide (90 µg/ml, final concentration) was added to D6P2T cells 30 min prior to harvesting in polysome solution (0.3 M NaCl, 10 mM Tris-Cl [pH 7.4], 10 mM MgCl2, 1.2% Triton X-100, 90 µg of cycloheximide per ml, 1 mg of heparin per ml). Cells were homogenized and centrifuged at 15,000 × g for 5 min, and the supernatant was layered onto 0.5 to 1.5 M sucrose gradients. The gradients were centrifuged for 90 min at 49,600 rpm in an SW65 rotor. Fractions were collected from the bottom. RNA was isolated from each fraction by using TRI Reagent as described above. The RNA pellet was dissolved in RNase-free water and analyzed by Northern blotting as described above. The probe used for detection of p27 mRNA from the polysome gradients was prepared as described above, using the p27 cDNA. mRNA levels in each fraction were quantitated with a Chemilmager (Alpha Innotech).
Pulse-labeling and immunoprecipitation of p27. The cells were washed three times with DMEM lacking Met and Cys and then incubated in 3 ml of the same medium containing 200 µCi of 35S-labeled Met and Cys (Tran35S-label [ICN], 1,175 Ci/mmol) for 1 h. The cells were harvested by trypsinization and then resuspended in DMEM containing 10% calf serum to inactivate the trypsin. The cell number was determined with a hemacytometer; the cells were pelleted and then washed with Dulbecco's phosphate-buffered saline three times. The cells were suspended in a mixture containing 1% Triton X-100, 150 mM NaCl, 10 mM Tris-Cl (pH 7.4), 1 mM EDTA, 1 mM EGTA, 0.2 mM sodium orthovanadate, 1 mM NaF, 10 µg of aprotinin per ml, 10 µg of leupeptin per ml, 1 mM phenylmethylsulfonyl fluoride, and 10% glycerol at 1.4 × 104 cells per µl. The cell suspension was briefly sonicated and then centrifuged at full speed in a microcentrifuge at 4°C for 20 min. A portion of the supernatant representing 1.4 × 105 cells was precipitated with trichloroacetic acid to estimate the level of total protein synthesis. The remainder of the cell extract was incubated with 2 µg of rabbit anti-p27 polyclonal antibody (sc-776; Santa Cruz Biotechnology) for 7 h with gentle shaking at 4°C. Protein A-conjugated agarose beads (30 µl) were added, and the incubation continued for 1 h on a rotator. The mixture was centrifuged at 1,200 × g to pellet the beads. The beads were washed five times with lysis buffer. After the final wash, the supernatant was discarded and 60 µl of SDS-sample buffer was added. After heating at 50°C for 5 min, the sample was loaded on an SDS-10% polyacrylamide gel.
| |
RESULTS |
|---|
|
|
|---|
To test the hypothesis that the 5'-UTR of the p27 mRNA can mediate cap-independent translation, we used the bicistronic expression vector pGL2CAT/Luc (8). The mRNA expressed from this vector carries both the CAT and luciferase coding regions separated by a short spacer region. The CAT coding region is near the 5' end and is translated in a cap-dependent manner. However, since the luciferase coding region is downstream of the CAT stop codon, it is expressed only if a sequence is inserted into the spacer region that can mediate cap-independent translation. For these experiments, we used the p27 5'-UTR from a cDNA cloned by Toyoshima and Hunter (39) from a mouse macrophage cell line. This fragment, which includes 217 bases upstream of the AUG start codon, was inserted between the CAT and luciferase genes in the bicistronic vector to construct pGL2CAT/Luc-p27UTR.
pGL2CAT/Luc-p27UTR and pGL2CAT/Luc were stably transfected into NIH 3T3
cells. These constructs should express a single mRNA that encodes for
both the CAT and luciferase genes. This was confirmed by isolating RNA
from the transfected cells and estimating the size of the mRNAs
expressed by Northern blotting (Fig. 1A).
The blots were first probed with a luciferase gene probe and then stripped and reprobed with a CAT gene probe. For each construct, both
probes identify a single band that migrates in the range of 3.6 kb,
which is near the predicted size of the expected mRNAs. No signal at
all was detected in untransfected 3T3 cells (not shown). The resolution
of the gel is not sufficient to distinguish the 217-nucleotide
difference in size of the mRNAs encoded by the vector and the construct
carrying the p27 5'-UTR. Thus, as expected, the CAT and luciferase
coding regions are expressed on a single mRNA molecule.
|
A portion of the same cell populations used to perform the Northern blots described above was used for analysis of both CAT and luciferase activities (Fig. 1B). Both the vector and the construct carrying the p27 5'-UTR efficiently expressed the CAT gene. However, only the construct with the p27 5'-UTR insert expressed significant levels of luciferase activity, indicating that this sequence is able to mediate cap-independent translation through an internal ribosome entry mechanism.
The ability of the p27 5'-UTR to mediate cap-independent translation
was further compared to those of other sequences inserted into the
spacer region between the CAT and luciferase coding regions. These
included the p27 5'-UTR inserted in the reverse orientation and a
200-bp segment of the human transferrin receptor (TR) 5'-UTR. These
constructs were transiently transfected into D6P2T cells and harvested
for analysis of CAT and luciferase activities after 1 day. All of the
constructs expressed similar levels of CAT activity, but only the
construct carrying the p27 5'-UTR in the forward orientation expressed
high levels of luciferase activity (Fig. 2A). Both the inverted p27 5'-UTR and the
TR 5'-UTR constructs expressed slightly higher levels of luciferase
than the pGL2CAT/Luc vector with no insert; however, the luciferase to
CAT ratio was only a small fraction of that observed with the p27
5'-UTR in the correct orientation (Fig. 2B). The activity of the p27
5'-UTR was also compared to that of a well-characterized mammalian
IRES, the BiP 5'-UTR (21). Bicistronic constructs carrying
these inserts were transiently transfected into D6P2T cells. Both
sequences were able to mediate cap-independent expression of
luciferase, although higher levels were observed with the p27 5'-UTR.
Also, the BiP construct, which utilizes the cytomegalovirus promoter rather than the simian virus 40 promoter, expresses a much higher level
of CAT than the p27 5'-UTR construct, indicating a higher level of
transcription from this construct. Therefore, the p27 5'-UTR is more
efficient at mediating cap-independent translation than the BiP IRES.
|
To further confirm these results, luciferase reporter constructs were
prepared in which an inverted repeat was inserted near the 5' end of
the transcribed region. In the mRNAs transcribed from these constructs,
the inverted repeat will result in the formation of a stable
hairpin-loop (
G =
61 kcal/mol) just downstream of
the 5' cap (16). Formation of this hairpin-loop will
effectively block cap-dependent initiation of translation but should
have little effect on internal ribosome assembly (16, 31).
In transiently transfected NIH 3T3 cells, the control construct, in
which the luciferase coding region is under the control of the
cytomegalovirus promoter (Fig. 3A, Luc), is efficiently expressed.
Placing a hairpin-loop upstream of the luciferase coding region near
the 5' end of the transcript (IR-Luc) nearly eliminates luciferase
expression (Fig. 3A). This indicates
that, as expected, the hairpin-loop blocks cap-dependent translation.
However, when the p27 5'-UTR is inserted between the hairpin-loop and
the luciferase coding region (IR-p27-Luc), high-level expression of
luciferase is restored. There is a 40-fold increase in expression when
the p27 5'-UTR is placed downstream of the hairpin-loop, further
demonstrating that the p27 5'-UTR is able to mediate cap-independent
translation.
|
It is notable that there is about a threefold increase in expression when the p27 5'-UTR is placed upstream of the luciferase coding region (p27-Luc) compared to the same construct without the 5'-UTR (Luc) (Fig. 3). This suggests that the p27 5'-UTR is able to enhance translational initiation. In addition, although the construct encoding the hairpin-loop upstream of the p27 5'-UTR (IR-p27-Luc) is expressed at significant levels, its activity is only about 30% of that of the construct without the inverted repeat (p27-Luc) (Fig. 3B). This suggests that p27 can be translated in a cap-dependent manner as well as through an internal ribosome entry mechanism. However, it is also possible that the presence of the strong hairpin-loop affects the conformation of the 5'-UTR and therefore interferes with cap-independent initiation.
The p27 5'-UTR sequence used in the experiments described above
includes the 217 nucleotides immediately upstream of the p27 start
codon. This region contains some features commonly found in other
IRESs, including a polypyrimidine tract upstream of the start codon and
the potential to form extensive secondary structure (11).
To determine the position of the sequences that are able to promote
internal ribosome assembly, two additional bicistronic constructs were
made. One construct encompasses the proximal portion of the 5'-UTR
(nucleotides 71 to 217) and includes the polypyrimidine tract; the
other construct encompasses the distal portion (nucleotides 1 to 90) of
the p27 5'-UTR. In transfection assays in D6P2T cells, both the
proximal and distal portions of the p27 5'-UTR were able to mediate
luciferase expression (Fig. 4). However,
neither was able to support the level of expression observed with the
full-length 5'-UTR. CAT expression levels were nearly identical with
all of the constructs, indicating that the differences in luciferase activity reflect differences in the efficiency of internal ribosome assembly. Apparently the IRES within the p27 5'-UTR consists of multiple sequence elements, which is consistent with reports on other
IRESs (8, 36).
|
Internal, cap-independent initiation of translation through the p27
5'-UTR should not be significantly affected by conditions that lead to
inhibition of eIF4E. eIF4E activity is blocked by hypophosphorylated
4E-BP, resulting in a general inhibition of cap-dependent translation.
Phosphorylation of 4E-BP results in dissociation from eIF4E and
enhanced cap-dependent translation. The drug rapamycin blocks 4E-BP
phosphorylation and has previously been shown to inhibit cap-dependent
translation but not IRES-dependent translation (2, 33).
When D6P2T cells were transfected with the p27 5'-UTR bicistronic
construct and then treated with rapamycin, there was no effect on
luciferase expression whereas CAT expression was reduced by nearly
one-third (Fig. 5A). The decrease
in CAT activity corresponds to the appearance of the active
hypophosphorylated form (
form) of 4E-BP, as shown by Western
blotting (Fig. 5B). These results support the conclusion that the p27
5'-UTR mediates cap-independent translation that is resistant to
rapamycin, similar to previous findings for other IRESs (2,
33).
|
The results above suggest that p27 5'-UTR-mediated internal initiation
allows translation to continue even when cap-dependent translation is
inhibited. To verify this, the bicistronic p27 5'-UTR construct was
cotransfected into D6P2T cells with an expression vector encoding a
mutant 4E-BP1. This 4E-BP mutant is altered at five amino acid
positions that are normally targets for phosphorylation (27). Mothe-Satney et al. (27) have shown
that since the expressed protein cannot be phosphorylated at the
appropriate sites, it is constitutively active in the inhibition of
eIF4E and cap-dependent translation. They have also shown that the
mutant protein does not interfere with IRES activity (27).
Coexpression of the mutant 4E-BP with the p27 5'-UTR bicistronic
reporter in D6P2T cells led to increased luciferase/CAT ratios (Fig.
6A) that paralleled increased levels of
mutant 4E-BP (Fig. 6B). This is the expected result if cap-dependent
translation is inhibited. In addition, the activity of the mutant 4E-BP
was compared with the activity of the wild-type 4E-BP in cotransfection
experiments with the p27 5'-UTR bicistronic construct in NIH 3T3 cells
(Fig. 6C). Both the wild-type and mutant proteins were able to enhance
the luciferase/CAT ratio. However, the activity of the mutant was
approximately twofold greater than the wild-type level, which is
consistent with the previous findings of Mothe-Satney et al.
(27) for the ability of these two proteins to inhibit
cap-dependent translation. These results further verify that the p27
5'-UTR is able to mediate cap-independent translation that is resistant
to inhibition of eIF4E activity.
|
We have previously shown that when D6P2T cells are treated with
reagents that elevate cyclic AMP levels, they rapidly exit the cell
cycle (reference 8 and Fig.
7A). Western blotting indicates that cell cycle exit induced by the addition of
isobutylmethylxanthine (IBMX) is accompanied by a striking increase in
p27 protein levels (Fig. 7B). Coincident with the increase in p27
protein levels there is a shift of p27 mRNA molecules to denser
polysomes, as determined by Northern blotting of fractions from
polysome sucrose gradients (Fig. 7C). In addition, experiments using
pulse-labeling with 35S-labeled amino acids followed by
immunoprecipitation of p27 show about a twofold increase in p27
synthesis 24 h after treatment with IBMX (Fig. 7D). These
experiments indicate that translational initiation of the p27 mRNA is
enhanced when D6P2T cells exit the cell cycle. This occurs despite the
fact that total protein synthesis is decreased by ~27% (Fig. 7D).
|
In D6P2T cells transfected with the bicistronic reporter constructs, addition of IBMX leads to enhanced cap-independent translation mediated by the p27 5'-UTR (Fig. 7E). This is indicated by a ~2-fold increase in normalized luciferase activity (luciferase/CAT ratio) in IBMX-treated cells compared to untreated cells. The slight activity observed for the pGL2CAT/Luc vector is actually inhibited under similar conditions. Thus, the process of internal ribosome assembly within the p27 5'-UTR appears to be specifically activated as the cells stop proliferating.
We further analyzed the activity of the 5'-UTR by expressing
epitope-tagged p27 in D6P2T cells (Fig.
8). Two constructs were prepared; one
retained the full 217-bp p27 5'-UTR described in the experiments above,
and the other retained only 3 bp upstream of the AUG start codon. For
both constructs, the 5' end of encoded mRNAs includes a ~115-bp
sequence derived from the vector. Therefore, the only difference
between the expressed sequence of the two clones is the presence or
absence of 214 bp of the p27 5'-UTR in its normal position relative to
the start codon. These two constructs were transfected into D6P2T cells
that had been treated with or without IBMX. The construct lacking the
p27 5'-UTR was expressed equally well and at high levels whether or not
the cells were proliferating or had exited the cell cycle in response
to IBMX. However, the construct which retained the p27 5'-UTR in its
normal position relative to the start codon was expressed at
significantly lower levels in proliferating cells than in IBMX-treated cells. Thus, the p27 5'-UTR in its normal context appears to limit expression in the proliferating cells but allow induction of high level
expression in quiescent cells. This activity coincides with increased
p27 5'-UTR-mediated cap-independent translation.
|
| |
DISCUSSION |
|---|
|
|
|---|
The results shown here demonstrate that the 5'-UTR of the p27 mRNA is capable of mediating cap-independent translation. This conclusion is supported by a number of different experimental approaches. The p27 5'-UTR supports translation of luciferase when its coding region is placed downstream of the CAT coding region in a bicistronic mRNA. This activity is not blocked by rapamycin, which specifically represses cap-dependent translation but not cap-independent translation (2, 33). Also, p27 5'-UTR-mediated cap-independent translation is not inhibited by coexpression with constitutively active 4E-BP, which binds to and inactivates eIF4E, the rate-limiting factor for cap-dependent translation (6). Finally, positioning a very stable hairpin-loop upstream of the start codon in a luciferase expression construct leads to a nearly complete inhibition of expression. This inhibition is reversed by inserting the p27 5'-UTR between the hairpin-loop and the luciferase start codon, strongly supporting the conclusion that the 5'-UTR mediates internal initiation of translation.
Using mouse T cells, Kwon et al. (17) found two major transcription start sites which mapped 200 or 252 nucleotides upstream of the AUG start codon. In contrast, using mouse kidney RNA, Zhang and Lin (41) found evidence for a major transcriptional start site ~500 nucleotides upstream of the AUG start codon. The p27 5'-UTR used for our experiments was derived from a mouse macrophage cDNA cloned by Toyoshima and Hunter (39) and includes 217 nucleotides upstream of the AUG start codon. Therefore, the 5' end of the sequence that we have analyzed lies between the two start sites of Kwon et al. (17). Deletion analysis has indicated that multiple elements within this 217-bp sequence contribute to IRES activity. Deletion of either 70 bases from the 5' end or 127 bases from the 3' end of the 5'-UTR reduces but does not eliminate IRES activity. Interestingly, the 3' end deletion removes a polypyrimidine tract ~40 nucleotides upstream of the start codon. A similar sequence in the human p27 mRNA has recently been shown to enhance translational initiation and to bind several proteins, including HuR, hnRNP C1, and hnRNP C2 (24). Zhao et al. (42) identified an endonuclease which is able to cleave within the HuR binding site of the human p27 5'-UTR and have shown that HuR inhibits cleavage by the endonuclease. This suggests that the polypyrimidine tract may function in message stability. It is not known whether it also affects cap-independent translation. However, our results (Fig. 4 and unpublished data) indicate that the polypyrimidine tract is not absolutely essential for IRES activity.
The importance of cap-independent translation of the p27 mRNA is that it provides a mechanism to escape the effects of global inhibition of cap-dependent translation that occur when eIF4E activity is downregulated. This occurs in response to contact inhibition, mitogen deprivation, amino acid starvation, and numerous other treatments. These are precisely the conditions in which p27 must be expressed at elevated levels in order to facilitate cell cycle arrest. By mediating internal initiation of translation, the p27 5'-UTR bypasses the need for eIF4E and the inhibitor can continue to be synthesized at significant levels.
It is possible that the p27 mRNA can be translated through both cap-dependent and cap-independent mechanisms. This is suggested by the fact that a luciferase construct containing a stable hairpin-loop upstream of the p27 5'-UTR is expressed at about 30% of the level of the same construct without the hairpin-loop. This may be because the stable hairpin-loop blocks scanning initiated from the 5' cap, but it is also possible that the hairpin-loop influences internal initiation by affecting the structure of the 5'-UTR. If the p27 mRNA can be translated through both mechanisms, it is expected that cap-independent initiation will be the predominant mode under conditions where eIF4E activity is low.
It is very likely that modulation of p27 5'-UTR IRES activity is an important mechanism in determining the cellular levels of p27. We have shown in quiescent D6P2T cells, cap-independent translation through the 5'-UTR is specifically enhanced and may be an important factor in the observed increase in p27 protein levels. Presumably, internal ribosome entry is initiated by proteins that recognize specific sequences or structures within the p27 5'-UTR, as shown for other IRESs (12, 35, 37). Such factors would functionally replace eIF4E and eliminate the need for 5' cap recognition. The activity of these factors may be modulated in response to differentiation signals and downregulated or inactivated in proliferating cells.
Finally, the inability to translate p27 by a cap-independent mechanism could contribute to the loss of p27 expression observed in many tumor cells. It is interesting that eIF4E is expressed at elevated levels in many tumors (5, 15, 19, 26, 28) and that overexpression of eIF4E leads to transformation of cultured cells (18, 23, 38). It is possible that high levels of eIF4E lead to sequestration of factors that are also needed for internal initiation of translation and that this contributes to inefficient synthesis of the p27 protein.
| |
ACKNOWLEDGMENTS |
|---|
We thank T. Hunter for the mouse p27 cDNA construct, R. E. Rhoads for pGL2CAT/Luc, L. Hudson for the BiP construct, and John Lawrence, Jr., for the mutant PHAS-1 construct. We thank Lew Bowman for protocols and advice for polysome gradient experiments.
This work was supported by NIH grants NS36164 (R.M.) and CA84325 (W.K.M.).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: University of South Dakota School of Medicine, Division of Basic Biomedical Sciences, 414 E. Clark St., Vermillion, SD 57069. Phone: (605) 677-5132. Fax: (605) 677-6381. E-mail: kmiskimi{at}usd.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Agrawal, D., P. Hauser, F. McPherson, F. Dong, A. Garcia, and W. J. Pledger. 1996. Repression of p27kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells. Mol. Cell. Biol. 16:4327-4336[Abstract]. |
| 2. | Beretta, L., A. C. Gingras, Y. V. Svitkin, M. N. Hall, and N. Sonenberg. 1996. Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J. 15:658-664[Medline]. |
| 3. |
Clurman, B. E., and P. Porter.
1998.
New insights into the tumor suppression function of P27(kip1).
Proc. Natl. Acad. Sci. USA
95:15158-15160 |
| 4. | Dahia, P. L., R. C. Aguiar, J. Honegger, R. Fahlbush, S. Jordan, D. G. Lowe, X. Lu, R. N. Clayton, G. M. Besser, and A. B. Grossman. 1998. Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours. Oncogene 16:69-76[CrossRef][Medline]. |
| 5. | De Benedetti, A., and A. L. Harris. 1999. eIF4E expression in tumors: its possible role in progression of malignancies. Int. J. Biochem. Cell Biol. 31:59-72[CrossRef][Medline]. |
| 6. |
Duncan, R.,
S. C. Milburn, and J. W. Hershey.
1987.
Regulated phosphorylation and low abundance of HeLa cell initiation factor eIF-4F suggest a role in translational control. Heat shock effects on eIF-4F.
J. Biol. Chem.
262:380-388 |
| 7. | Ferrando, A. A., M. Balbin, A. M. Pendas, F. Vizoso, G. Velasco, and C. Lopez-Otin. 1996. Mutational analysis of the human cyclin-dependent kinase inhibitor p27kip1 in primary breast carcinomas. Hum. Genet. 97:91-94[CrossRef][Medline]. |
| 8. | Gan, W., M. L. Celle, and R. E. Rhoads. 1998. Functional characterization of the internal ribosome entry site of eIF4G mRNA. J. Biol. Chem. 276:5006-5012. |
| 9. | Haghighat, A., S. Mader, A. Pause, and N. Sonenberg. 1995. Repression of cap-dependent translation by 4E-binding protein 1: competition with p220 for binding to eukaryotic initiation factor-4E. EMBO J. 14:5701-5709[Medline]. |
| 10. | Hengst, L., and S. I. Reed. 1996. Translational control of p27Kip1 accumulation during the cell cycle. Science 271:1861-1864[Abstract]. |
| 11. | Houdebine, L. M., and J. Attal. 1999. Internal ribosome entry sites (IRESs): reality and use. Transgenic Res. 8:157-177[CrossRef][Medline]. |
| 12. |
Hunt, S. L.,
J. J. Hsuan,
N. Totty, and R. J. Jackson.
1999.
unr, a cellular cytoplasmic RNA-binding protein with five cold-shock domains, is required for internal initiation of translation of human rhinovirus RNA.
Genes Dev.
13:437-448 |
| 13. | Jones, R. M., J. Branda, K. A. Johnston, M. Polymenis, M. Gadd, A. Rustgi, L. Callanan, and E. V. Schmidt. 1996. An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc. Mol. Cell. Biol. 16:4754-4764[Abstract]. |
| 14. |
Kawamata, N.,
R. Morosetti,
C. W. Miller,
D. Park,
K. S. Spirin,
T. Nakamaki,
S. Takeuchi,
Y. Hatta,
J. Simpson, and S. Wilcyznski.
1995.
Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies.
Cancer Res.
55:2266-2269 |
| 15. | Kerekatte, V., K. Smiley, B. Hu, A. Smith, F. Gelder, and A. De Benedetti. 1995. The proto-oncogene/translation factor eIF4E: a survey of its expression in breast carcinomas. Int. J. Cancer 64:27-31[Medline]. |
| 16. |
Kozak, M.
1989.
Circumstances and mechanisms of inhibition of translation by secondary structure in eucaryotic mRNAs.
Mol. Cell. Biol.
9:5134-5142 |
| 17. | Kwon, T. K., J. E. Nagel, M. A. Buchholz, and A. A. Nordin. 1996. Characterization of the murine cyclin-dependent kinase inhibitor gene p27Kip1. Gene 180:113-120[CrossRef][Medline]. |
| 18. |
Lazaris-Karatzas, A., and N. Sonenberg.
1992.
The mRNA 5' cap-binding protein, eIF-4E, cooperates with v-Myc or E1A in the transformation of primary rodent fibroblasts.
Mol. Cell. Biol.
12:1234-1238 |
| 19. | Li, B. D., L. Liu, M. Dawson, and A. De Benedetti. 1997. Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinoma. Cancer 79:2385-2390[CrossRef][Medline]. |
| 20. |
Lloyd, R. V.,
L. A. Erickson,
L. Jin,
E. Kulig,
X. Qian,
J. C. Cheville, and B. W. Scheithauer.
1999.
p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers.
Am. J. Pathol.
154:313-323 |
| 21. | Macejak, D. G., and P. Sarnow. 1991. Internal initiation of translation mediated by the 5' leader of a cellular mRNA. Nature 353:90-94[Medline]. |
| 22. | Mader, S., H. Lee, A. Pause, and N. Sonenberg. 1995. The translation initiation factor eIF-4E binds to a common motif shared by the translation factor eIF-4 gamma and the translational repressors 4E-binding proteins. Mol. Cell. Biol. 15:4990-4997[Abstract]. |
| 23. | McKendrick, L., V. M. Pain, and S. J. Morley. 1999. Translation initiation factor 4E. Int. J. Biochem. Cell Biol. 31:31-35[CrossRef][Medline]. |
| 24. |
Millard, S. S.,
A. Vidal,
M. Markus, and A. Koff.
2000.
A U-rich element in the 5' untranslated region is necessary for the translation of p27 mRNA.
Mol. Cell. Biol.
20:5947-5959 |
| 25. |
Millard, S. S.,
J. S. Yan,
H. Nguyen,
M. Pagano,
H. Kiyokawa, and A. Koff.
1997.
Enhanced ribosomal association of p27(Kip1) mRNA is a mechanism contributing to accumulation during growth arrest.
J. Biol. Chem.
272:7093-7098 |
| 26. | Miyagi, Y., A. Sugiyama, A. Asai, T. Okazaki, Y. Kuchino, and S. J. Kerr. 1995. Elevated levels of eukaryotic translation initiation factor eIF-4E, mRNA in a broad spectrum of transformed cell lines. Cancer Lett. 91:247-252[CrossRef][Medline]. |
| 27. |
Mothe-Satney, I.,
D. Yang,
P. Fadden,
T. A. Haystead, and J. C. Lawrence, Jr.
2000.
Multiple mechanisms control phosphorylation of PHAS-I in five (S/T)P sites that govern translational repression.
Mol. Cell. Biol.
20:3558-3567 |
| 28. | Nathan, C. A., S. Franklin, F. W. Abreo, R. Nassar, A. De Benedetti, J. Williams, and F. J. Stucker. 1999. Expression of eIF4E during head and neck tumorigenesis: possible role in angiogenesis. Laryngoscope 109:1253-1258[CrossRef][Medline]. |
| 29. |
Ouyang, Q.,
M. Bommakanti, and W. K. Miskimins.
1993.
A mitogen-responsive promoter region that is synergistically activated through multiple signalling pathways.
Mol. Cell. Biol.
13:1796-1804 |
| 30. |
Pagano, M.,
S. W. Tam,
A. M. Theodoras,
P. Beer-Romero,
G. Del Sal,
V. Chau,
P. R. Yew,
G. F. Draetta, and M. Rolfe.
1995.
Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.
Science
269:682-685 |
| 31. | Pelletier, J., and N. Sonenberg. 1988. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 334:320-325[CrossRef][Medline]. |
| 32. |
Ponce-Castaneda, M. V.,
M. H. Lee,
E. Latres,
K. Polyak,
L. Lacombe,
K. Montgomery,
S. Mathew,
K. Krauter,
J. Sheinfeld, and J. Massague.
1995.
p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors.
Cancer Res.
55:1211-1214 |
| 33. | Pyronnet, S., L. Pradayrol, and N. Sonenberg. 2000. A cell cycle-dependent internal ribosome entry site. Mol. Cell 5:607-616[CrossRef][Medline]. |
| 34. |
Rhoads, R. E.
1999.
Signal transduction pathways that regulate eukaryotic protein synthesis.
J. Biol. Chem.
274:30337-30340 |
| 35. | Sachs, A. B., P. Sarnow, and M. W. Hentze. 1997. Starting at the beginning, middle, and end: translation initiation in eukaryotes. Cell 89:831-838[CrossRef][Medline]. |
| 36. |
Sella, O.,
G. Gerlitz,
S. Y. Le, and O. Elroy-Stein.
1999.
Differentiation-induced internal translation of c-sis mRNA: analysis of the cis elements and their differentiation-linked binding to the hnRNP C protein.
Mol. Cell. Biol.
19:5429-5240 |
| 37. |
Sizova, D. V.,
V. G. Kolupaeva,
T. V. Pestova,
I. N. Shatsky, and C. U. Hellen.
1998.
Specific interaction of eukaryotic translation initiation factor 3 with the 5' nontranslated regions of hepatitis C virus and classical swine fever virus RNAs.
J. Virol.
72:4775-4782 |
| 38. | Smith, M. R., M. Jaramillo, Y. L. Liu, T. E. Dever, W. C. Merrick, H. F. Kung, and N. Sonenberg. 1990. Translation initiation factors induce DNA synthesis and transform NIH 3T3 cells. New Biol. 2:648-654[Medline]. |
| 39. | Toyoshima, H., and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67-74[CrossRef][Medline]. |
| 40. |
Waskiewicz, A. J.,
J. C. Johnson,
B. Penn,
M. Mahalingam,
S. R. Kimball, and J. A. Cooper.
1999.
Phosphorylation of the cap-binding protein eukaryotic translation initiation factor 4E by protein kinase Mnk1 in vivo.
Mol. Cell. Biol.
19:1871-1880 |
| 41. | Zhang, Y., and S. C. Lin. 1997. Molecular characterization of the cyclin-dependent kinase inhibitor p27 promoter. Biochim. Biophys. Acta 1353:307-317[Medline]. |
| 42. |
Zhao, Z.,
F. C. Chang, and H. M. Furneaux.
2000.
The identification of an endonuclease that cleaves within an HuR binding site in mRNA.
Nucleic Acids Res.
28:2695-2701 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»